Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...

CureWise, the AI-powered platform Steve originally developed to help with his own rare blood cancer diagnosis, has evolved ...

Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.

The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...

Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has contributed to CURE as a blogger ...

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...